Table 2.
The distribution of T- and Z-scores in Turkish patients with rheumatoid arthritis with and without anti-citrullinated protein antibody
| ACPA (+) n=45 | ACPA (−) n=48 | p | |
|---|---|---|---|
| Age (years) | 61.8±8.7 | 58.4±8.8 | NS |
| Gender (male/female) | 4/41 | 2/46 | NS |
| Disease Duration (months) | 61.6±28.6 | 50.4±26.6 | NS |
| Steroid Dose (mg) | 8.3±8.2 | 8.3±7.8 | NS |
| DAS28-ESR | 3.8±1.1 | 3.9±0.9 | NS |
| Rheumatoid Factor Positivity n (%) | 29 (64.4) | 9 (18.8) | <0.001* |
| T-score | |||
| • Lumbar | −2.3±1.0 | −2.4±0.9 | |
| • Femoral neck | −2.0±0.9 | −1.7±1.1 | NS |
| • Total hip | −1.1±1.2 | −0.8±1.2 | |
| Z-score | |||
| • Lumbar | −1.1±1.0 | −0.8±1.2 | NS |
| • Femoral neck | −0.6±0.7 | −0.1±1.1 | 0.03* |
| • Total hip | −0.8±1.1 | −0.1±1.2 | NS |
*
p<0.05
NS: not significant; DAS28-ESR: disease activity score 28-erythrocyte sedimentation rate; ACPA: anti-citrullinated protein antibody